1 in 90 C-19 Vaccine Hospitalisation rate in NZ

Official information act request reveals excessive adverse events that continue long after 3 weeks.

(Note: 14/11/2023. This post got inadvertently deleted so I’m posting it again- sorry if you’ve read it before)

The NZ Ministry of Health (MoH)sponsored a pre-print study in the Lancet entitled ‘Adverse events following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand’. The paper, uploaded on February 3 2023, looked at hospitalisation rates for 12 conditions noted to be ‘Adverse Events of Special Interest’ (AESIs) for the 3 weeks following vaccination. It identified an uptick in hospitalisation for Acute Kidney Failure (AKI) and myo/percarditis, but the rest were judged to be ‘not statistically different than the expected rates.’ The paper compared the hospitalisation rates found in 2021 with those documented by a group of researchers at Auckland University who prepared a study into background rates from 2008-2019 in NZ (known as the S.A.F.E. Project).

One problem with the study is that in NZ, vaccination status is recorded on hospital admission as it was 7 days prior. This means that any search of the database will probably not return, as vaccinated, anyone who went to hospital within one week of being jabbed. In other words the first week of AESIs will be missed. If you scale up the results in the report by 3/2 the outcome is a significant increase in the rates for all AESIs.

Another problem is the baseless assumption that AESIs only occur within 3 weeks. This might be at least partially true of traditional vaccines, but mRNA shots are a completely new technology- you can’t apply what we’ve learned from conventional vaccines automatically to mRNA jabs and expect that to stick just because you want it to- we need more evidence.

After reading the Feb 3 study, I made an Official Information Act request to discover the numbers of all the AESIs throughout the whole of 2021 to ascertain whether yearly rates were up by more than that identified by the MoH study. The reply from the Ministry of Health to my OIA can be accessed here.

I draw your attention to the last table:

Below is my analysis thus far. The number of admissions from the table above is given in column 2, & the expected annual rate from the SAFE report in column 4. The calculated expected number in column 5 is based on the population given by Statistics NZ for June 2021, and the resulting excess hospitalisations in column 6 is the result of subtracting the expected in column 5 from the actual admissions in column 2.

As can be seen, the result is 42,110 more hospitalisations than expected for these AESIs alone. That would be the equivalent of 2.5m hospitalisations in the US or around 600k in the UK. This is considerably higher than the MoH study count and falsifies the ‘all adverse events occur in 3 weeks’ theory.

Since NZ had practically no Covid until 2022 there is only one likely contender for the culprit… the vaccine. This association proves stronger when we consider that the Feb MoH study has already demonstrated a considerable increase in Acute Kidney Injury and Myo/Pericarditis (which gets even larger when re-calculated to allow for the missing first week of data).

For the record, the AKI hospitalisation rate is 1 per 110, the Myo/Percarditis rate is 1 per 4000, and the overall rate of hospitalisation for adverse events is about 1 in 90. That’s absolutely horrific, but it is what the data says, or to translate into Jacinder-ese: ‘it is what it is’!

B.T.W, it’s no secret that NZ’s health system has been completely swamped over the past 2 years. Can anyone still pretend not to know why?

If you have another explanation then let’s hear it.

As there were only 12 out of 39 AESIs assessed, the actual figure of excess hospitalisation is much larger than this. Some notable AESIs not assessed are Anaphylaxis, Arrythmia, Coronary Artery Disease, and Heart Failure. I have made a second OIA request to get the data on all AESIs. Stay tuned…